441 related articles for article (PubMed ID: 24265104)
1. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia.
Soravia LM; Heinrichs M; Winzeler L; Fisler M; Schmitt W; Horn H; Dierks T; Strik W; Hofmann SG; de Quervain DJ
Depress Anxiety; 2014 May; 31(5):429-35. PubMed ID: 24265104
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cortisol levels influence exposure therapy in spider phobia.
Lass-Hennemann J; Michael T
Behav Res Ther; 2014 Sep; 60():39-45. PubMed ID: 25051297
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure cortisol administration does not augment the success of exposure therapy: A randomized placebo-controlled study.
Raeder F; Merz CJ; Tegenthoff M; Wolf OT; Margraf J; Zlomuzica A
Psychoneuroendocrinology; 2019 Jan; 99():174-182. PubMed ID: 30245330
[TBL] [Abstract][Full Text] [Related]
4. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
5. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
[TBL] [Abstract][Full Text] [Related]
6. The relative contributions of fear and disgust reductions to improvements in spider phobia following exposure-based treatment.
Olatunji BO; Huijding J; de Jong PJ; Smits JA
J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):117-21. PubMed ID: 20732677
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids reduce phobic fear in humans.
Soravia LM; Heinrichs M; Aerni A; Maroni C; Schelling G; Ehlert U; Roozendaal B; de Quervain DJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5585-90. PubMed ID: 16567641
[TBL] [Abstract][Full Text] [Related]
8. One-session computer-based exposure treatment for spider-fearful individuals--efficacy of a minimal self-help intervention in a randomised controlled trial.
Müller BH; Kull S; Wilhelm FH; Michael T
J Behav Ther Exp Psychiatry; 2011 Jun; 42(2):179-84. PubMed ID: 21315879
[TBL] [Abstract][Full Text] [Related]
9. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
10. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample?
Shiban Y; Brütting J; Pauli P; Mühlberger A
J Behav Ther Exp Psychiatry; 2015 Mar; 46():133-40. PubMed ID: 25460259
[TBL] [Abstract][Full Text] [Related]
11. Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.
Minns S; Levihn-Coon A; Carl E; Smits JAJ; Miller W; Howard D; Papini S; Quiroz S; Lee-Furman E; Telch M; Carlbring P; Xanthopoulos D; Powers MB
J Anxiety Disord; 2018 Aug; 58():1-7. PubMed ID: 29909286
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid administration restores salience network activity in patients with spider phobia.
Soravia LM; Schwab S; Weber N; Nakataki M; Wiest R; Strik W; Heinrichs M; de Quervain D; Federspiel A
Depress Anxiety; 2018 Oct; 35(10):925-934. PubMed ID: 30099829
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement.
Steudte-Schmiedgen S; Fay E; Capitao L; Kirschbaum C; Reinecke A
J Psychopharmacol; 2021 Jun; 35(6):641-651. PubMed ID: 33908295
[TBL] [Abstract][Full Text] [Related]
14. Contamination-Focused Exposure as a Treatment for Disgust-Based Fears: A Preliminary Test in Spider-Fearful Women.
Cougle JR; Summers BJ; Harvey AM; Dillon KH; Allan NP
Behav Cogn Psychother; 2016 Nov; 44(6):640-651. PubMed ID: 27465309
[TBL] [Abstract][Full Text] [Related]
15. Internet-based self-help versus one-session exposure in the treatment of spider phobia: a randomized controlled trial.
Andersson G; Waara J; Jonsson U; Malmaeus F; Carlbring P; Ost LG
Cogn Behav Ther; 2009; 38(2):114-20. PubMed ID: 20183690
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids enhance extinction-based psychotherapy.
de Quervain DJ; Bentz D; Michael T; Bolt OC; Wiederhold BK; Margraf J; Wilhelm FH
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6621-5. PubMed ID: 21444799
[TBL] [Abstract][Full Text] [Related]
18. Delaying in vivo exposure to a tarantula with very brief exposure to phobic stimuli.
Siegel P; Gallagher KA
J Behav Ther Exp Psychiatry; 2015 Mar; 46():182-8. PubMed ID: 25460265
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled clinical trial of in virtuo and in vivo exposure for spider phobia.
Michaliszyn D; Marchand A; Bouchard S; Martel MO; Poirier-Bisson J
Cyberpsychol Behav Soc Netw; 2010 Dec; 13(6):689-95. PubMed ID: 21142994
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined multiple contexts and multiple stimuli exposure in spider phobia: A randomized clinical trial in virtual reality.
Shiban Y; Schelhorn I; Pauli P; Mühlberger A
Behav Res Ther; 2015 Aug; 71():45-53. PubMed ID: 26072451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
